Relationship between faecal metronidazole and lactoferrin concentrations to clinical response of patients with Clostridioides difficile

Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1781-1784. doi: 10.1007/s10096-020-03895-8. Epub 2020 Apr 12.

Abstract

Objectives: We investigated patients with Clostridioides difficile-associated diarrhoea to see if clinical resolution correlated with faecal concentrations of metronidazole or markers of inflammation.

Methods: Faecal metronidazole, lactoferrin and serum CRP were measured daily. These were then compared with clinical progress.

Results: Metronidazole concentration correlated with lactoferrin (ρ = 0.17, p = 0.015), CRP (ρ = 0.23, p < 0.001) and number of diarrhoeal stools per day (ρ = 0.29, p < 0.001). Lactoferrin correlated with CRP (ρ = 0.57, p < 0.001) and the number of diarrhoeal stools per day (ρ = 0.52, p < 0.001) as did CRP (ρ = 0.52, p < 0.001).

Conclusions: We found no association between cessation of diarrhoea and metronidazole or lactoferrin concentrations. There was a relationship between metronidazole concentrations and markers of inflammation and stool frequency.

Keywords: Clostridioides difficile; Faecal lactoferrin; Faecal metronidazole.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile / drug effects*
  • Clostridioides difficile / metabolism
  • Enterocolitis, Pseudomembranous / blood
  • Enterocolitis, Pseudomembranous / drug therapy*
  • Enterocolitis, Pseudomembranous / microbiology
  • Feces / chemistry
  • Female
  • Humans
  • Lactoferrin / metabolism*
  • Male
  • Metronidazole / metabolism
  • Metronidazole / pharmacology*
  • Metronidazole / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Metronidazole
  • Lactoferrin